FoundationOne CDx test
Term · Oncology and biomedicine · MLC-T-ONC-003333
A laboratory test done on a tumor tissue sample to help match a patient's tumor to a specific drug or therapy. A FoundationOne CDx test looks at many different genes in the tissue sample to help identify whether a patient’s tumor has a specific gene mutation (change) or biomarker that is targeted by a particular drug or therapy. This helps determine whether the drug might be an effective treatment for the patient's tumor. A FoundationOne CDx test is a type of companion diagnostic test. FoundationOne is a registered trademark of Foundation Medicine, Inc. Also called F1CDx test.
| Identifier | MLC-T-ONC-003333 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | F1CDx test |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003333",
"term": "FoundationOne CDx test",
"field": "Oncology and biomedicine",
"definition": "A laboratory test done on a tumor tissue sample to help match a patient's tumor to a specific drug or therapy. A FoundationOne CDx test looks at many different genes in the tissue sample to help identify whether a patient’s tumor has a specific gene mutation (change) or biomarker that is targeted by a particular drug or therapy. This helps determine whether the drug might be an effective treatment for the patient's tumor. A FoundationOne CDx test is a type of companion diagnostic test. FoundationOne is a registered trademark of Foundation Medicine, Inc. Also called F1CDx test.",
"synonyms": [
"F1CDx test"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/foundationone-cdx-test/"
}
Record 7,594 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.